E Moitinho Selected Research

Propranolol (Inderal)

1/2003	Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Transjugular intrahepatic portosystemic shunt.
8/2001	Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Moitinho Research Topics

Disease

4	Hemorrhage 12/2001 - 03/2000
2	Pathologic Constriction (Stenosis) 01/2003 - 07/2001
2	Liver Failure 08/2001 - 07/2001
1	Fibrosis (Cirrhosis) 08/2001
1	Hypotension (Low Blood Pressure) 08/2001
1	Ascites 07/2001
1	Gastrointestinal Hemorrhage (Hematochezia) 04/2001
1	Hemobilia 01/2001
1	Portal Hypertension 01/2001
1	Neoplasms (Cancer) 09/2000
1	Peritonitis 09/2000
1	Hepatocellular Carcinoma (Hepatoma) 09/2000

Drug/Important Bio-Agent (IBA)

2	Propranolol (Inderal)FDA LinkGeneric 01/2003 - 08/2001
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2001
1	Losartan (Cozaar)FDA LinkGeneric 08/2001
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2001
1	CreatinineIBA 09/2000
1	Cephalosporins (Cephalosporin Antibiotics)IBA 09/2000
1	BilirubinIBA 09/2000
1	QuinolonesIBA 09/2000
1	Norfloxacin FDA Link 09/2000
1	AlbuminsIBA 09/2000
1	hypertensive factorIBA 03/2000

Therapy/Procedure

3	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2003 - 01/2001
2	Transjugular Intrahepatic Portasystemic Shunt 01/2003 - 07/2001
1	Ligation 04/2001
1	Transplantation 09/2000